Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

• Published in: Endocrine practice Vol. 26; no. 1; pp. 107 - 139
• Main Authors: Garber, Alan J., Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bush, Michael A., DeFronzo, Ralph A., Garber, Jeffrey R., Garvey, W.Timothy, Hirsch, Irl B., Jellinger, Paul S., McGill, Janet B., Mechanick, Jeffrey I., Perreault, Leigh, Rosenblit, Paul D., Samson, Susan, Umpierrez, Guillermo E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 01.01.2020
• Subjects: Algorithms; Blood Glucose; Blood Glucose Self-Monitoring; Carbohydrates; Chronic illnesses; Clinical medicine; Consensus; Counseling; Diabetes; Diabetes Mellitus, Type 2; Diabetic ketoacidosis; Endocrinologists; Endocrinology; Ethnicity; Fatty acids; FDA approval; Food; Glucose; Humans; Hypoglycemia; Insulin resistance; Intervention; Lifestyles; Lipids; Meals; Metabolism; Nutrition; Obesity; Patients; Prevention; Proprotein Convertase 9; United States; Weight control; United States
• ISSN: 1530-891X; 1934-2403; 1934-2403
• DOI: 10.4158/CS-2019-0472

Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control Cardiovascular Risk in Diabetes; ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure; ACE = American College of Endocrinology; ACEI = angiotensin-converting enzyme inhibitor; AGI = alpha-glucosidase inhibitor; apo B = apolipoprotein B; ARB = angiotensin II receptor blocker; ASCVD = atherosclerotic cardiovascular disease; BAS = bile acid sequestrant; BMI = body mass index; BP = blood pressure; CCB = calcium channel blocker; CGM = continuous glucose monitoring; CHD = coronary heart disease; CKD = chronic kidney disease; DKA = diabetic ketoacidosis; DPP4 = dipeptidyl peptidase 4; eGFR = estimated glomerular filtration rate; EPA = eicosapentaenoic acid; ER = extended release; FDA = Food and Drug Administration; GLP1 = glucagon-like peptide 1; HDL-C = high-density-lipoprotein cholesterol; HeFH = heterozygous familial hypercholesterolemia; LDL-C = low-density-lipoprotein cholesterol; LDL-P = low-density-lipoprotein particle; Look AHEAD = Look Action for Health in Diabetes; NPH = neutral protamine Hagedorn; OSA = obstructive sleep apnea; PCSK9 = proprotein convertase subtilisin-kexin type 9 serine protease; RCT = randomized controlled trial; SU = sulfonylurea; SGLT2 = sodium-glucose cotransporter 2; SMBG = self-monitoring of blood glucose; T2D = type 2 diabetes; TZD = thiazolidinedione